138 related articles for article (PubMed ID: 38173668)
1. Survival Following Palliative Radiotherapy for Head and Neck Squamous Cell Carcinoma: Examining Treatment Indications in Elderly Patients.
Katano A; Minamitani M; Tongyu G; Ohira S; Yamashita H
Cancer Diagn Progn; 2024; 4(1):46-50. PubMed ID: 38173668
[TBL] [Abstract][Full Text] [Related]
2. The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly.
Haehl E; Rühle A; Klink R; Kalckreuth T; Sprave T; Gkika E; Zamboglou C; Meiß F; Grosu AL; Nicolay NH
Radiat Oncol; 2021 Jun; 16(1):105. PubMed ID: 34118984
[TBL] [Abstract][Full Text] [Related]
3. Survival Patterns in Elderly Head and Neck Squamous Cell Carcinoma Patients Treated With Definitive Radiation Therapy.
Sommers LW; Steenbakkers RJHM; Bijl HP; Vemer-van den Hoek JGM; Roodenburg JLN; Oosting SF; Halmos GB; de Rooij SE; Langendijk JA
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):793-801. PubMed ID: 28476434
[TBL] [Abstract][Full Text] [Related]
4. The role of split-course hypofractionated palliative radiotherapy in head and neck cancer.
Kancherla KN; Oksuz DC; Prestwich RJ; Fosker C; Dyker KE; Coyle CC; Sen M
Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):141-8. PubMed ID: 20934860
[TBL] [Abstract][Full Text] [Related]
5. Palliative Local Radiotherapy for Advanced Squamous Cell Carcinoma of the Head-and-Neck: Prognostic Factors of Survival.
Staackmann C; Ribbat-Idel J; Perner S; Idel C; Bruchhage KL; Hakim SG; Schild SE; Rades D
Anticancer Res; 2021 Jun; 41(6):3205-3210. PubMed ID: 34083316
[TBL] [Abstract][Full Text] [Related]
6. Palliative Radiotherapy for Cutaneous Squamous Cell Carcinoma of the Head-and-Neck Region.
Staackmann C; Schild SE; Rades D
In Vivo; 2021; 35(4):2283-2288. PubMed ID: 34182507
[TBL] [Abstract][Full Text] [Related]
7. Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy?
Bonomo P; Desideri I; Loi M; Lo Russo M; Olmetto E; Maragna V; Francolini G; Delli Paoli C; Grassi R; Pezzulla D; Greto D; Meattini I; Livi L
Oral Oncol; 2017 Nov; 74():142-147. PubMed ID: 29103743
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Factors Predict Oncological Outcome in Older Patients With Head and Neck Cancer Undergoing Chemoradiation Treatment.
Stromberger C; Yedikat B; Coordes A; Tinhofer I; Kalinauskaite G; Budach V; Zschaeck S; Raguse JD; Kofla G; Heiland M; Stsefanenka A; Beck-Broichsitter B; Dommerich S; Senger C; Beck M
Front Oncol; 2020; 10():566318. PubMed ID: 33708616
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a novel prognostic score for elderly head-and-neck cancer patients undergoing radiotherapy or chemoradiation.
Rühle A; Stromberger C; Haehl E; Senger C; David H; Stoian R; Zamboglou C; Knopf A; Budach V; Grosu AL; Nicolay NH
Radiother Oncol; 2021 Jan; 154():276-282. PubMed ID: 33245947
[TBL] [Abstract][Full Text] [Related]
12. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
[TBL] [Abstract][Full Text] [Related]
13. Karnofsky Performance Score - An Independent Prognostic Factor of Survival After Palliative Irradiation for Sino-nasal Cancer.
Rades D; Staackmann C; Schild SE
Anticancer Res; 2021 May; 41(5):2495-2499. PubMed ID: 33952477
[TBL] [Abstract][Full Text] [Related]
14. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial to identify the optimal radiotherapy scheme for palliative treatment of incurable head and neck squamous cell carcinoma.
Al-Mamgani A; Kessels R; Verhoef CG; Navran A; Hamming-Vrieze O; Kaanders JHAM; Steenbakkers RJHM; Tans L; Hoebers F; Ong F; van Werkhoven E; Langendijk JA
Radiother Oncol; 2020 Aug; 149():181-188. PubMed ID: 32417345
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy.
Rühle A; Marschner S; Haderlein M; Fabian A; Weymann M; Behrens M; Senger C; Dickstein DR; Kraft J; von der Grün J; Chen E; Aquino-Michaels T; Domschikowski J; Bickel A; Altay-Langguth A; Kalinauskaite G; Lewitzki V; Ferentinos K; Zamboglou C; Schnellhardt S; Haehl E; Spohn SKB; Gkika E; Zöller D; Guckenberger M; Budach V; Belka C; Bakst R; Mayer A; Schmidberger H; Grosu AL; Balermpas P; Stromberger C; Nicolay NH
JAMA Netw Open; 2023 Feb; 6(2):e230090. PubMed ID: 36808242
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of curative treatment for head and neck squamous cell carcinoma in very elderly adults ≥80 years old.
Wilson T; Fleischer L; Patel S; Bhatnagar A; Ahmad N; Kubicek G
Head Neck; 2022 Nov; 44(11):2370-2377. PubMed ID: 35822453
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the accuracy of clinical prediction of survival and palliative prognostic index for patients with head and neck squamous cell carcinoma in the end-of-life setting.
Kishino T; Monden N; Akisada N; Hayashi Y; Nakamura M; Hashimoto K; Miyashita T; Mori T; Hoshikawa H
Auris Nasus Larynx; 2022 Feb; 49(1):133-140. PubMed ID: 34226098
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?
Haehl E; Rühle A; David H; Kalckreuth T; Sprave T; Stoian R; Becker C; Knopf A; Grosu AL; Nicolay NH
Radiat Oncol; 2020 Feb; 15(1):31. PubMed ID: 32019576
[TBL] [Abstract][Full Text] [Related]
20. Retrospective study of palliative radiotherapy in newly diagnosed head and neck carcinoma.
Stevens CM; Huang SH; Fung S; Bayley AJ; Cho JB; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; O'Sullivan B; Waldron JN; Ringash J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):958-63. PubMed ID: 20950952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]